https://doctransparency.com/doctor/fl/miami/michael-weitz-1639145337
Medicare Enrolled

Dr. Michael Weitz, MD

Rheumatology · Miami, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
7190 SW 87TH AVE, Miami, FL 33173
3056612299
In practice since 2006 (20 years)
NPI: 1639145337 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weitz

Dr. Michael Weitz is a rheumatology in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Weitz performed 165,995 Medicare services across 4,295 unique beneficiaries.

Between the years covered by Open Payments, Dr. Weitz received a total of $927,958 from 52 pharmaceutical and/or device companies across 1666 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weitz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 13% volume in FL$ $927,958 industry payments

Medicare Practice Summary

Medicare Utilization ↗
165,995
Medicare services
Top 13% in FL for rheumatology
4,295
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,300 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Romosozumab injection (Evenity) for osteoporosis56,072$8$18
Certolizumab injection (Cimzia)36,000$4$14
Denosumab injection (Prolia/Xgeva)33,960$18$42
Golimumab infusion (Simponi Aria)16,554$10$34
Abatacept infusion (Orencia)8,050$34$90
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg4,320$13$113
Steroid injection (triamcinolone)3,046$1$4
Extended-release steroid injection (Zilretta)2,048$13$38
Office visit, established patient (20-29 min)959$71$158
Office visit, established patient (30-39 min)593$99$233
Drug injection, under skin or into muscle432$12$44
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less421$54$157
Joint injection, major joint384$62$202
Bone density scan (DEXA)328$41$136
Administration of chemotherapy into vein, 1 hour or less295$110$306
Injection into tendon at attachment to bone or muscle283$32$98
X-ray of lower and sacral spine, minimum of 4 views188$41$105
X-ray of hand, minimum of 3 views187$31$69
X-ray of pelvis, 1-2 views180$23$69
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle180$62$173
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose160$99$270
X-ray of middle spine, 2 views141$27$73
Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve)108$172$463
Shoulder X-ray, 2+ views99$29$63
Aspiration and/or injection of fluid large joint using ultrasound guidance93$113$302
Knee X-ray, 3 views91$32$77
Injection, zoledronic acid, 1 mg91$6$24
Administration of chemotherapy into vein, each additional hour88$24$67
Foot X-ray, 3+ views84$28$63
Aspiration and/or injection of fluid from small joint61$40$122
X-ray of upper spine, 6 or more views56$52$120
New patient office visit (45-59 min)48$135$364
X-ray of both hips, 2 views45$34$80
Chest X-ray, 2 views40$29$65
X-ray of knee, 4 or more views38$39$85
Mri scan of leg joint without contrast35$104$507
Mri scan of arm joint without contrast34$103$507
New patient office visit (30-44 min)34$96$240
Mri scan of lower spinal canal without contrast27$99$480
Office visit, established patient, complex (40-54 min)26$136$316
X-ray of lower and sacral spine, 2-3 views25$33$75
Flu vaccine administration22$33$56
Aspiration and/or injection of fluid from medium joint21$37$114
Flu vaccine, quadrivalent21$75$120
Injection into tendon or ligament16$41$120
Office visit, established patient (10-19 min)11$36$97
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.1% high complexity
83.0% medium
1.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$927,958
Total received (2018-2024)
Avg $132,565/year across 7 years
Top 1% in FL for rheumatology
52
Companies
1,666
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$897,369 (96.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,746 (2.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,414 (0.7%)
Scientific / Research
Research funding and grants
$429 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$33,733
2023
$50,865
2022
$84,205
2021
$69,016
2020
$98,690
2019
$291,218
2018
$300,231

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$279,967
Lilly USA, LLC
$206,604
Janssen Scientific Affairs, LLC
$166,484
Radius Health, Inc.
$87,871
Janssen Biotech, Inc.
$58,515
E.R. Squibb & Sons, L.L.C.
$26,522
Novartis Pharmaceuticals Corporation
$25,247
Celgene Corporation
$24,891
UCB, Inc.
$20,510
Genentech USA, Inc.
$10,163
GENZYME CORPORATION
$8,322
Regeneron Healthcare Solutions, Inc.
$6,928
ABBVIE INC.
$1,084
AbbVie Inc.
$703
ANI Pharmaceuticals, Inc.
$500
Johnson & Johnson Health Care Systems Inc.
$436
SANOFI-AVENTIS U.S. LLC
$424
Aurinia Pharma U.S., Inc.
$323
AbbVie, Inc.
$322
PFIZER INC.
$280
DePuy Synthes Sales Inc.
$218
MEDAC PHARMA, INC.
$137
Horizon Therapeutics plc
$127
Mallinckrodt Hospital Products Inc.
$120
GlaxoSmithKline, LLC.
$119
Gilead Sciences, Inc.
$116
AstraZeneca Pharmaceuticals LP
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$94
Kiniksa Pharmaceuticals International, plc
$93
Alvogen Inc
$87
Fresenius Kabi USA, LLC
$68
Organon LLC
$64
Mallinckrodt LLC
$63
Mallinckrodt Enterprises LLC
$61
Pacira Pharmaceuticals Incorporated
$53
Alexion Pharmaceuticals, Inc.
$41
Janssen Pharmaceuticals, Inc
$38
Shire North American Group Inc
$32
Exeltis, USA Inc.
$23
ASCEND Therapeutics US, LLC
$23
TerSera Therapeutics LLC
$21
Egalet US Inc
$20
SCILEX PHARMACEUTICALS INC.
$19
Antares Pharma, Inc.
$19
Fidia Pharma USA Inc.
$17
Bioventus LLC
$16
Sobi, Inc
$15
Zyla Life Sciences
$13
Iroko Pharmaceuticals, LLC
$13
MEDEXUS PHARMA, INC.
$13
Horizon Pharma plc
$12
FIDIA PHARMA USA INC.
$5
Top 3 companies account for 70.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BECONASE · BENLYSTA · BINOSTO · COSENTYX · CYLTEZO · Cimzia · DUEXIS · EVENITY · EVUSHELD · Enbrel · GAMMAGARD · GELSYN-3 · HADLIMA · HUMIRA · HYMOVIS · Humira · Hymovis · ILARIS · INFLECTRA · Iovera · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · NO PRODUCT DISCUSSED · OLUMIANT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · PEAK · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tremfya · Tymlos · VIVLODEX · XELJANZ · ZORVOLEX · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for rheumatology in FL.

Equivalent to $559 per 100 Medicare services performed
Looking for a rheumatology in Miami?
Compare rheumatologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
72
Per 100K population
2.7
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
3.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Weitz is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Weitz experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Weitz performed 56,072 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weitz receive payments from pharmaceutical companies?
Yes. Dr. Weitz received a total of $927,958 from 52 companies across 1,666 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weitz's costs compare to other rheumatologys in Miami?
Dr. Weitz's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →